STANDARD BIOTOOLS INC. (LAB) Total liabilities 2016–2025
STANDARD BIOTOOLS INC. (LAB) total liabilities at each fiscal year-end, per SEC filings.
$143.5MFY2025 · since FY2016: $253.2M → $143.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $143.5M | +2.0% |
| FY2024 | $140.6M | -12.0% |
| FY2023 | $159.9M | -0.4% |
| FY2022 | $160.5M | -11.1% |
| FY2021 | $180.6M | -2.7% |
| FY2020 | $185.7M | +67.0% |
| FY2019 | $111.2M | -52.0% |
| FY2018 | $231.5M | -9.7% |
| FY2017 | $256.4M | +1.3% |
| FY2016 | $253.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice